Description
April 14, 2026
Clinical Lab Fee Schedule Data Collection Webinar
Medicare Learning Network: Is My Lab an Applicable Lab? (CMS video)
Preparing for PAMA Reporting in 2026 (CAP)
CAP House of Delegates & Pathologists Leadership Summit 2026
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
Virginia bans insurers from steering tests to preferred labs. A new AI tool to treat a deadly cancer. End Hill Day. These stories and more coming up next. This is Path News Network Daily Edition from the College of American Pathologists. I'm Nick Lanyi. It's Tuesday, April 14th. Health insurers in Virginia can no longer steer pathology tests to their preferred laboratories, thanks to a bill signed into law last week by Governor Abigail Spanberger. The CAP and the Virginia Society for Pathology supported the legislation, which sets a national precedent at the state law level to address an insurance industry practice that can harm patients. Some health insurers were steering tests to only one or two labs, with some tests occurring out of state. That can delay diagnoses, cause logistical complications, and prevent doctors from choosing the in-network lab they deem best for a particular test. The legislation passed the Virginia legislature unanimously. New private payer data reporting rules for hospitals, physician offices, and independent laboratories go into effect May 1st. The Centers for Medicare and Medicaid Services is hosting a one-hour webinar on the new Protecting Access to Medicare Act requirements. on Thursday, April 16th at 3 p.m. Eastern Time. The webinar will cover qualifying criteria for laboratories, what data will be collected, how to register, and how to prepare. CMS also has a new video on its YouTube site explaining the new requirements and how to determine if your lab is eligible. Or, see the CAP website for more resources, including a two-pager with frequently asked questions. A new AI tool could help doctors treat patients with extensive-stage small-cell lung cancer, or SCLC, according to a new study published in NPJA Precision Oncology. Patients with extensive-stage SCLC have an average survival rate of about 12 months. Because there are no known biomarkers for subtypes of SCLC, all patients typically undergo the same treatment, platinum-based chemotherapy. Researchers used the AI tool to examine whole slide images of the patient's pathology slides and quantify the spatial organization and density of immune and tumor cells. This information successfully identified patients less likely to respond to platinum-based chemo, a determination that usually occurs only after weeks of treatment. Early identification of such patients could steer them more quickly to other treatments. The team that developed the tool Thank you. called PhenopyCell, was co-led by Dr. Prantesh Jain of Roswell Park Comprehensive Cancer Center in Buffalo, New York, and Dr. Anant Madabhushi of Winship Cancer Institute of Emory University in Atlanta. The CAP's House of Delegates and Pathologists Leadership Summit starts April 25th in Washington, D.C. One of the highlights is the annual Hill Day, when pathologists from around the country, head to Capitol Hill, to meet with members of Congress and their staffs. It's one of the most effective ways to advocate for legislation that helps pathologists improve patient care. Dr. Meredith Pittman, a surgical pathologist at Maimonides Medical Center in New York City and a member of the CAP Federal and State Affairs Committee, went to her first Hill Day in 2024. She had encouraging words for pathologists who would like to attend but aren't sure what to expect.
I would say that, first of all, the CAP does a great job of supporting you before Hill Day and at Hill Day. There's a whole session about how do you talk to legislators, what to expect. You will definitely be paired with someone who has done this before. You're not going to be sent out all by yourself. You're not going to be, you know, stuck in a room with a staff member and you don't know what to say. That's just not the way the CAP runs this. It's a very well-oiled machine they have put together. So, if that's your worry and that's what would keep you from going, don't worry about that.
Dr. Pittman was impressed by the Hill staffers she met.
They were just really bright and really on top of things, and it made me very hopeful as I talked to them that they were understanding where we were coming from and that the things we said and the information we left with them was going to be taken seriously and that they understood what we were telling them.
She added that one of the benefits is simply meeting fellow pathologists from different places and specialties.
It is exciting to be with a group of people who are all joined in like a common mission to go up to the Hill and to advocate for health care, to advocate on behalf of pathologists, to advocate on behalf of our patients getting the laboratory testing and treatment that they deserve. And that is, it's just a really interesting and I thought very enjoyable day. I had a great time, which is why I'm going back.
It's not too late to sign up for this year's Hill Day. See the CAP website to register. And that's it for today. For more information on today's stories, please see the show notes. Got a story we should be covering? Write to us at stories at cap.org. We'll be back Wednesday at 5 a.m. Eastern for another episode of Daily Edition. I'm Nick Lanyi. Have a wonderful day.
Description
April 14, 2026
Clinical Lab Fee Schedule Data Collection Webinar
Medicare Learning Network: Is My Lab an Applicable Lab? (CMS video)
Preparing for PAMA Reporting in 2026 (CAP)
CAP House of Delegates & Pathologists Leadership Summit 2026
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
Virginia bans insurers from steering tests to preferred labs. A new AI tool to treat a deadly cancer. End Hill Day. These stories and more coming up next. This is Path News Network Daily Edition from the College of American Pathologists. I'm Nick Lanyi. It's Tuesday, April 14th. Health insurers in Virginia can no longer steer pathology tests to their preferred laboratories, thanks to a bill signed into law last week by Governor Abigail Spanberger. The CAP and the Virginia Society for Pathology supported the legislation, which sets a national precedent at the state law level to address an insurance industry practice that can harm patients. Some health insurers were steering tests to only one or two labs, with some tests occurring out of state. That can delay diagnoses, cause logistical complications, and prevent doctors from choosing the in-network lab they deem best for a particular test. The legislation passed the Virginia legislature unanimously. New private payer data reporting rules for hospitals, physician offices, and independent laboratories go into effect May 1st. The Centers for Medicare and Medicaid Services is hosting a one-hour webinar on the new Protecting Access to Medicare Act requirements. on Thursday, April 16th at 3 p.m. Eastern Time. The webinar will cover qualifying criteria for laboratories, what data will be collected, how to register, and how to prepare. CMS also has a new video on its YouTube site explaining the new requirements and how to determine if your lab is eligible. Or, see the CAP website for more resources, including a two-pager with frequently asked questions. A new AI tool could help doctors treat patients with extensive-stage small-cell lung cancer, or SCLC, according to a new study published in NPJA Precision Oncology. Patients with extensive-stage SCLC have an average survival rate of about 12 months. Because there are no known biomarkers for subtypes of SCLC, all patients typically undergo the same treatment, platinum-based chemotherapy. Researchers used the AI tool to examine whole slide images of the patient's pathology slides and quantify the spatial organization and density of immune and tumor cells. This information successfully identified patients less likely to respond to platinum-based chemo, a determination that usually occurs only after weeks of treatment. Early identification of such patients could steer them more quickly to other treatments. The team that developed the tool Thank you. called PhenopyCell, was co-led by Dr. Prantesh Jain of Roswell Park Comprehensive Cancer Center in Buffalo, New York, and Dr. Anant Madabhushi of Winship Cancer Institute of Emory University in Atlanta. The CAP's House of Delegates and Pathologists Leadership Summit starts April 25th in Washington, D.C. One of the highlights is the annual Hill Day, when pathologists from around the country, head to Capitol Hill, to meet with members of Congress and their staffs. It's one of the most effective ways to advocate for legislation that helps pathologists improve patient care. Dr. Meredith Pittman, a surgical pathologist at Maimonides Medical Center in New York City and a member of the CAP Federal and State Affairs Committee, went to her first Hill Day in 2024. She had encouraging words for pathologists who would like to attend but aren't sure what to expect.
I would say that, first of all, the CAP does a great job of supporting you before Hill Day and at Hill Day. There's a whole session about how do you talk to legislators, what to expect. You will definitely be paired with someone who has done this before. You're not going to be sent out all by yourself. You're not going to be, you know, stuck in a room with a staff member and you don't know what to say. That's just not the way the CAP runs this. It's a very well-oiled machine they have put together. So, if that's your worry and that's what would keep you from going, don't worry about that.
Dr. Pittman was impressed by the Hill staffers she met.
They were just really bright and really on top of things, and it made me very hopeful as I talked to them that they were understanding where we were coming from and that the things we said and the information we left with them was going to be taken seriously and that they understood what we were telling them.
She added that one of the benefits is simply meeting fellow pathologists from different places and specialties.
It is exciting to be with a group of people who are all joined in like a common mission to go up to the Hill and to advocate for health care, to advocate on behalf of pathologists, to advocate on behalf of our patients getting the laboratory testing and treatment that they deserve. And that is, it's just a really interesting and I thought very enjoyable day. I had a great time, which is why I'm going back.
It's not too late to sign up for this year's Hill Day. See the CAP website to register. And that's it for today. For more information on today's stories, please see the show notes. Got a story we should be covering? Write to us at stories at cap.org. We'll be back Wednesday at 5 a.m. Eastern for another episode of Daily Edition. I'm Nick Lanyi. Have a wonderful day.
Share
Embed
You may also like
Description
April 14, 2026
Clinical Lab Fee Schedule Data Collection Webinar
Medicare Learning Network: Is My Lab an Applicable Lab? (CMS video)
Preparing for PAMA Reporting in 2026 (CAP)
CAP House of Delegates & Pathologists Leadership Summit 2026
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
Virginia bans insurers from steering tests to preferred labs. A new AI tool to treat a deadly cancer. End Hill Day. These stories and more coming up next. This is Path News Network Daily Edition from the College of American Pathologists. I'm Nick Lanyi. It's Tuesday, April 14th. Health insurers in Virginia can no longer steer pathology tests to their preferred laboratories, thanks to a bill signed into law last week by Governor Abigail Spanberger. The CAP and the Virginia Society for Pathology supported the legislation, which sets a national precedent at the state law level to address an insurance industry practice that can harm patients. Some health insurers were steering tests to only one or two labs, with some tests occurring out of state. That can delay diagnoses, cause logistical complications, and prevent doctors from choosing the in-network lab they deem best for a particular test. The legislation passed the Virginia legislature unanimously. New private payer data reporting rules for hospitals, physician offices, and independent laboratories go into effect May 1st. The Centers for Medicare and Medicaid Services is hosting a one-hour webinar on the new Protecting Access to Medicare Act requirements. on Thursday, April 16th at 3 p.m. Eastern Time. The webinar will cover qualifying criteria for laboratories, what data will be collected, how to register, and how to prepare. CMS also has a new video on its YouTube site explaining the new requirements and how to determine if your lab is eligible. Or, see the CAP website for more resources, including a two-pager with frequently asked questions. A new AI tool could help doctors treat patients with extensive-stage small-cell lung cancer, or SCLC, according to a new study published in NPJA Precision Oncology. Patients with extensive-stage SCLC have an average survival rate of about 12 months. Because there are no known biomarkers for subtypes of SCLC, all patients typically undergo the same treatment, platinum-based chemotherapy. Researchers used the AI tool to examine whole slide images of the patient's pathology slides and quantify the spatial organization and density of immune and tumor cells. This information successfully identified patients less likely to respond to platinum-based chemo, a determination that usually occurs only after weeks of treatment. Early identification of such patients could steer them more quickly to other treatments. The team that developed the tool Thank you. called PhenopyCell, was co-led by Dr. Prantesh Jain of Roswell Park Comprehensive Cancer Center in Buffalo, New York, and Dr. Anant Madabhushi of Winship Cancer Institute of Emory University in Atlanta. The CAP's House of Delegates and Pathologists Leadership Summit starts April 25th in Washington, D.C. One of the highlights is the annual Hill Day, when pathologists from around the country, head to Capitol Hill, to meet with members of Congress and their staffs. It's one of the most effective ways to advocate for legislation that helps pathologists improve patient care. Dr. Meredith Pittman, a surgical pathologist at Maimonides Medical Center in New York City and a member of the CAP Federal and State Affairs Committee, went to her first Hill Day in 2024. She had encouraging words for pathologists who would like to attend but aren't sure what to expect.
I would say that, first of all, the CAP does a great job of supporting you before Hill Day and at Hill Day. There's a whole session about how do you talk to legislators, what to expect. You will definitely be paired with someone who has done this before. You're not going to be sent out all by yourself. You're not going to be, you know, stuck in a room with a staff member and you don't know what to say. That's just not the way the CAP runs this. It's a very well-oiled machine they have put together. So, if that's your worry and that's what would keep you from going, don't worry about that.
Dr. Pittman was impressed by the Hill staffers she met.
They were just really bright and really on top of things, and it made me very hopeful as I talked to them that they were understanding where we were coming from and that the things we said and the information we left with them was going to be taken seriously and that they understood what we were telling them.
She added that one of the benefits is simply meeting fellow pathologists from different places and specialties.
It is exciting to be with a group of people who are all joined in like a common mission to go up to the Hill and to advocate for health care, to advocate on behalf of pathologists, to advocate on behalf of our patients getting the laboratory testing and treatment that they deserve. And that is, it's just a really interesting and I thought very enjoyable day. I had a great time, which is why I'm going back.
It's not too late to sign up for this year's Hill Day. See the CAP website to register. And that's it for today. For more information on today's stories, please see the show notes. Got a story we should be covering? Write to us at stories at cap.org. We'll be back Wednesday at 5 a.m. Eastern for another episode of Daily Edition. I'm Nick Lanyi. Have a wonderful day.
Description
April 14, 2026
Clinical Lab Fee Schedule Data Collection Webinar
Medicare Learning Network: Is My Lab an Applicable Lab? (CMS video)
Preparing for PAMA Reporting in 2026 (CAP)
CAP House of Delegates & Pathologists Leadership Summit 2026
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
Virginia bans insurers from steering tests to preferred labs. A new AI tool to treat a deadly cancer. End Hill Day. These stories and more coming up next. This is Path News Network Daily Edition from the College of American Pathologists. I'm Nick Lanyi. It's Tuesday, April 14th. Health insurers in Virginia can no longer steer pathology tests to their preferred laboratories, thanks to a bill signed into law last week by Governor Abigail Spanberger. The CAP and the Virginia Society for Pathology supported the legislation, which sets a national precedent at the state law level to address an insurance industry practice that can harm patients. Some health insurers were steering tests to only one or two labs, with some tests occurring out of state. That can delay diagnoses, cause logistical complications, and prevent doctors from choosing the in-network lab they deem best for a particular test. The legislation passed the Virginia legislature unanimously. New private payer data reporting rules for hospitals, physician offices, and independent laboratories go into effect May 1st. The Centers for Medicare and Medicaid Services is hosting a one-hour webinar on the new Protecting Access to Medicare Act requirements. on Thursday, April 16th at 3 p.m. Eastern Time. The webinar will cover qualifying criteria for laboratories, what data will be collected, how to register, and how to prepare. CMS also has a new video on its YouTube site explaining the new requirements and how to determine if your lab is eligible. Or, see the CAP website for more resources, including a two-pager with frequently asked questions. A new AI tool could help doctors treat patients with extensive-stage small-cell lung cancer, or SCLC, according to a new study published in NPJA Precision Oncology. Patients with extensive-stage SCLC have an average survival rate of about 12 months. Because there are no known biomarkers for subtypes of SCLC, all patients typically undergo the same treatment, platinum-based chemotherapy. Researchers used the AI tool to examine whole slide images of the patient's pathology slides and quantify the spatial organization and density of immune and tumor cells. This information successfully identified patients less likely to respond to platinum-based chemo, a determination that usually occurs only after weeks of treatment. Early identification of such patients could steer them more quickly to other treatments. The team that developed the tool Thank you. called PhenopyCell, was co-led by Dr. Prantesh Jain of Roswell Park Comprehensive Cancer Center in Buffalo, New York, and Dr. Anant Madabhushi of Winship Cancer Institute of Emory University in Atlanta. The CAP's House of Delegates and Pathologists Leadership Summit starts April 25th in Washington, D.C. One of the highlights is the annual Hill Day, when pathologists from around the country, head to Capitol Hill, to meet with members of Congress and their staffs. It's one of the most effective ways to advocate for legislation that helps pathologists improve patient care. Dr. Meredith Pittman, a surgical pathologist at Maimonides Medical Center in New York City and a member of the CAP Federal and State Affairs Committee, went to her first Hill Day in 2024. She had encouraging words for pathologists who would like to attend but aren't sure what to expect.
I would say that, first of all, the CAP does a great job of supporting you before Hill Day and at Hill Day. There's a whole session about how do you talk to legislators, what to expect. You will definitely be paired with someone who has done this before. You're not going to be sent out all by yourself. You're not going to be, you know, stuck in a room with a staff member and you don't know what to say. That's just not the way the CAP runs this. It's a very well-oiled machine they have put together. So, if that's your worry and that's what would keep you from going, don't worry about that.
Dr. Pittman was impressed by the Hill staffers she met.
They were just really bright and really on top of things, and it made me very hopeful as I talked to them that they were understanding where we were coming from and that the things we said and the information we left with them was going to be taken seriously and that they understood what we were telling them.
She added that one of the benefits is simply meeting fellow pathologists from different places and specialties.
It is exciting to be with a group of people who are all joined in like a common mission to go up to the Hill and to advocate for health care, to advocate on behalf of pathologists, to advocate on behalf of our patients getting the laboratory testing and treatment that they deserve. And that is, it's just a really interesting and I thought very enjoyable day. I had a great time, which is why I'm going back.
It's not too late to sign up for this year's Hill Day. See the CAP website to register. And that's it for today. For more information on today's stories, please see the show notes. Got a story we should be covering? Write to us at stories at cap.org. We'll be back Wednesday at 5 a.m. Eastern for another episode of Daily Edition. I'm Nick Lanyi. Have a wonderful day.
Share
Embed
You may also like